Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

International Affairs (IA) Working Group

International Affairs (IA) Working Group

BACK

International Affairs (IA) Working Group

Healthcare all over the world, should benefit from the rapid advances and the introduction of in silico methods in medicine. As realized n other industries, the application of in silico methods in medicine promises accelerated innovation and improved quality in the delivery of medical devices and pharmaceuticals to the marketplace. The valuable contribution of in silico methods as a complimentary source of evidence for regulatory submissions will not be achieved through academics and industry alone. Ultimately there needs to be strong collaboration with regulatory authorities around the world.

The objective of the Avicenna Alliance International Working Group is the promotion of the benefits of predictive medicine and in silico methods through the global connections of experts from academia, industry, and regulatory agencies. Together we will work on developing policies and standards, increasing confidence in in silico methods and promote the added value of in silico evidence to the regulatory approval process.

The key goals of this group are:

  • Facilitating dialogue on in silico with regulators and stakeholders around the world;
  • Supporting harmonization and regulatory reliance policies for in silico methods and in silico clinical trials;
  • Seek opportunities to expand the Alliance geographically.

Priorities 2023 - 2024 and beyond:

2023:

  • Pursue observer status with IMDRF and potential attendance to IMDRF EU conferences;
  • Organize an IMDRF event for modeling & simulation socialization in Brussels;
  • UK TF – Support UK Regulatory Roundtable for development of In Silico Standards;
  • Support the launch and strategic initiatives of the APAC Task Force.

2024:

  • Strategy for formal ongoing IMDRF engagement;
  • Organize local event with APAC regulators;
  • Participate in international events to represent the Avicenna Alliance.

2025 and beyond:

  • Continue to develop strategy and engagement for addressing regulatory policy needs across geographies;
  • Collaborate with other Avicenna Alliance Working Groups to accumulate artifacts and successful in silico applications for engagement with Regulators and Notified Bodies.

Marc Horner

Marc Horner

Leader of the International Affairs WG & Chair of the Global Harmonization TF

Distinguished Engineer, Ansys

READ BIO

NEWS

News In Silico Medicine: A New Scientific Discipline Emerges in Greece

In Silico Medicine: A New Scientific Discipline Emerges in Greece

On December 21, 2024, Research Professor Georgios S. Stamatakos, a great pioneer of in silico oncology, delivered a lecture in Sparta, Greece, exploring the emergence, evolution, and clinical potential of in silico medicine.

News Introducing the plain language in silico medicine glossary

Introducing the plain language in silico medicine glossary

As in silico medicine continues to advance, new concepts and terms emerge rapidly—often before widespread consensus is established. To make this transformative field more accessible to all the stakeholders including the patients, we are pleased to present the “Plain language in silico medicine glossary”, now published on Zenodo.

News Happy New Year, 2025, the Millennium Year

Happy New Year, 2025, the Millennium Year

Dear Avicenna Alliance members, As we welcome the new year, we hope you had a joyful holiday season filled with moments of relaxation and happiness with your loved ones.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry